Status:

COMPLETED

Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis

Lead Sponsor:

Hadassah Medical Organization

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

PHASE2

Brief Summary

An open prospective study with multiple (every 6-12 months) intrathecal or intravenous injections of autologous MSC in patients with progressive forms of MS (secondary progressive, primary progressive...

Detailed Description

An open prospective study with multiple intrathecal or intravenous injections of autologous MSC in 24 patients with progressive forms of MS (secondary progressive, primary progressive or relapsing-pro...

Eligibility Criteria

Inclusion

  • Consenting patients fulfilling the Poser's criteria for definite MS
  • Age 18-70
  • Male and female
  • EDSS rate 5.5-7.5 (moderate to high disability)
  • Failure to two lines of the currently available registered immunomodulatory treatments for MS. The lack of response to these treatments was determined by either an increase in EDSS or the appearance of at least two relapses of MS during the year prior to inclusion.

Exclusion

  • Patients who were treated with cytotoxic medications during the last three months prior to the infusion.
  • Patients suffering from significant cardiac, renal or hepatic failure or any other disease that may risk the patient or interfere with the ability to interpret the results.
  • Patients with active infections.
  • Patients with cognitive decline or inability to understand and sign the informed consent.

Key Trial Info

Start Date :

January 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2020

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04823000

Start Date

January 1 2013

End Date

April 1 2020

Last Update

March 30 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis | DecenTrialz